全球标准试剂市场：市场规模和份额分析（按技术、应用和方法）、工业需求预测（截至2030年）

市场概况

预计2023年全球标准试剂市场规模将达到16.189亿美元，2024年至2030年复合年增长率为7.0%，2030年将达25.881亿美元。 研究工作的标准是材料或化学品必须超过才能进一步使用的特定要求。 这些是“参考化合物”，对于确定分析物、确定未知物和品质保证测试至关重要。

在製药和生命科学领域，随着临床试验的增加，对分析化学品的需求也在增加。 例如，此类浓缩化合物可用于分析药物的化学和物理稳定性。

此外，生物製药领域在全球成长最快的标准试剂市场中占有重要地位。 标准试剂用途广泛，从测定和生物标记开发到实验室製造和测试，再到微量物质鑑定和纯度评估。

主要考虑因素

到 2023 年，色谱的行业份额为 25%，预计在预测期内将出现显着发展。

北美地区是标准试剂的主要市场，预测期内复合年增长率为7.2%。

该地区从当地工业、出口监管合规性以及该地区的高研发投资中受益匪浅。

本报告分析了全球标准试剂市场，包括市场的基本结构和最新情况、主要促进和抑制因素以及全球、按地区和主要国家的市场规模前景（以货币形式计算） ，（2017-2030） ，按技术、应用和方法划分的详细趋势，当前市场竞争状况以及主要公司概况。

目录

第1章研究范围

第2章研究方法

第 3 章执行摘要

第 4 章市场指标

第5章产业展望

• 市场动态
  • 趋势
  • 促进因素
  • 抑制因素/挑战
  • 促进/抑制因子影响分析
• 新型冠状病毒感染 (COVID-19) 的影响
• 波特五力分析

第6章世界市场

• 摘要
• 市场收入：依技术划分（2017-2030 年）
• 市场收入：依应用分类（2017-2030 年）
• 市场报酬：依方法划分（2017-2030 年）
• 市场收入：按地区划分（2017-2030 年）

第7章北美市场

• 摘要
• 市场收入：依技术划分（2017-2030 年）
• 市场收入：依应用分类（2017-2030 年）
• 市场报酬：依方法划分（2017-2030 年）
• 市场收入：依国家/地区划分（2017-2030 年）

第8章欧洲市场

第9章亚太市场

第10章拉丁美洲市场

第11章中东及非洲市场

第12章美国市场

• 摘要
• 市场收入：依技术划分（2017-2030 年）
• 市场收入：依应用分类（2017-2030 年）
• 市场报酬：依方法划分（2017-2030 年）

第13章加拿大市场

第14章德国市场

第15章法国市场

第16章英国市场

第17章义大利市场

第18章西班牙市场

第19章日本市场

第20章中国市场

第21章印度市场

第22章澳洲市场

第23章韩国市场

第24章巴西市场

第25章墨西哥市场

第26章沙乌地阿拉伯市场

第27章南非市场

第 28 章阿联酋 (UAE) 市场

第29章竞争态势

• 市场参与者及其提供的产品/服务的列表
• 主要公司的竞争基准
• 各大公司的产品基准
• 近期策略发展状况

第30章公司简介

• Merck KGaA
• Agilent Technologies Inc.
• Waters Corporation
• LGC Standards Ltd.
• PerkinElmer Inc.
• SPEX CertiPrep
• AccuStandard Inc.
• Thermo Fisher Scientific Inc.

第31章 附录

Market Overview

The analytical standards market size stood at USD 1,618.9 million in 2023, and it is expected to grow at a CAGR of 7.0% during 2024-2030, to reach USD 2,588.1 million by 2030. The standards for analytical work are the specific requirements that a material or chemical must exceed to be used further. They are 'reference compounds'; and they are vital in the determination of analytes, determination of unknown substances, and quality assurance testing.

The global market is providing the opportunity to launch products with high commercial viability in pharmaceutical and biotechnology, food safety and quality assurance, environmental analysis, forensics, and many other applications.

The necessity of analytical chemicals is more felt in the pharmaceutical and life sciences sector because of the increasing number of clinical trials. Such concentrated compounds are used to analyze the chemical and physical stability, for instance, of drugs.

As a result, the growing incidence of different diseases that drive drug R&D is projected to bring about a CAGR of 7.3% in the global pharmaceutical and life sciences sector in terms of the forecast period.

Additionally, the biopharmaceutical sector holds the position of the fastest-growing analytical standards marketplace in the world. The analytical standard compounds find a wide range of applications from developing assays and various biomarkers to their production and testing in the labs and the trace material identification and purity assessment.

Key Insights

In 2023, the chromatography category had a substantial industry share of 25% and is projected to witness significant development in the projection period.

Development is propelled by augmented research and development activities in drugs and biopharmaceuticals, along with technical improvements.

Chromatography plays an important role in noticing and separating chemical constituents, monitoring ecologies, studying distant galaxies, advancing medication effectiveness, and characterizing proteins.

The category's improvement is boosted by the increasing populace affected by chronic illnesses, leading to augmented demand for medications.

The North American region is the dominating industry for analytical standards, with an anticipated CAGR of 7.2% during the projection period.

The region benefits a lot from the local industry, export compliance imposed by regulatory authorities, as well as the high R&D investment in the area.

The major makers of reference compounds in North America are the primary source of a large sale of the compounds to the pharmaceutical and chemical industries

The use of analytical technologies is growing in daily life to achieve many purposes in the lab such as environmental monitoring, drug testing, forensic use, food testing, and so on.

The U.S. and Canada, with high per capita incomes and supportive state policies, are experiencing growth in the market by giving people more access to healthcare services.

The contamination of food is a substantial worldwide health concern, leading to food-borne contagions, allergies, and intoxication.

More than 600 million individuals are affected by food-borne diseases yearly, resulting in around 420,000 demises and 33 million healthy life years lost.

Food-borne diseases cause approximately USD 95 billion in productivity loss in low- and middle-income countries, with global treatment costs reaching around USD 15 billion annually.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by technique
  • 1.4.2. Market size breakdown, by application
  • 1.4.3. Market size breakdown, by methodology
  • 1.4.4. Market size breakdown, by region
  • 1.4.5. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Technique (2017-2030)
• 6.3. Market Revenue, by Application (2017-2030)
• 6.4. Market Revenue, by Methodology (2017-2030)
• 6.5. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Technique (2017-2030)
• 7.3. Market Revenue, by Application (2017-2030)
• 7.4. Market Revenue, by Methodology (2017-2030)
• 7.5. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Technique (2017-2030)
• 8.3. Market Revenue, by Application (2017-2030)
• 8.4. Market Revenue, by Methodology (2017-2030)
• 8.5. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Technique (2017-2030)
• 9.3. Market Revenue, by Application (2017-2030)
• 9.4. Market Revenue, by Methodology (2017-2030)
• 9.5. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Technique (2017-2030)
• 10.3. Market Revenue, by Application (2017-2030)
• 10.4. Market Revenue, by Methodology (2017-2030)
• 10.5. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Technique (2017-2030)
• 11.3. Market Revenue, by Application (2017-2030)
• 11.4. Market Revenue, by Methodology (2017-2030)
• 11.5. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Technique (2017-2030)
• 12.3. Market Revenue, by Application (2017-2030)
• 12.4. Market Revenue, by Methodology (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Technique (2017-2030)
• 13.3. Market Revenue, by Application (2017-2030)
• 13.4. Market Revenue, by Methodology (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Technique (2017-2030)
• 14.3. Market Revenue, by Application (2017-2030)
• 14.4. Market Revenue, by Methodology (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Technique (2017-2030)
• 15.3. Market Revenue, by Application (2017-2030)
• 15.4. Market Revenue, by Methodology (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Technique (2017-2030)
• 16.3. Market Revenue, by Application (2017-2030)
• 16.4. Market Revenue, by Methodology (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Technique (2017-2030)
• 17.3. Market Revenue, by Application (2017-2030)
• 17.4. Market Revenue, by Methodology (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Technique (2017-2030)
• 18.3. Market Revenue, by Application (2017-2030)
• 18.4. Market Revenue, by Methodology (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Technique (2017-2030)
• 19.3. Market Revenue, by Application (2017-2030)
• 19.4. Market Revenue, by Methodology (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Technique (2017-2030)
• 20.3. Market Revenue, by Application (2017-2030)
• 20.4. Market Revenue, by Methodology (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Technique (2017-2030)
• 21.3. Market Revenue, by Application (2017-2030)
• 21.4. Market Revenue, by Methodology (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Technique (2017-2030)
• 22.3. Market Revenue, by Application (2017-2030)
• 22.4. Market Revenue, by Methodology (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Technique (2017-2030)
• 23.3. Market Revenue, by Application (2017-2030)
• 23.4. Market Revenue, by Methodology (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Technique (2017-2030)
• 24.3. Market Revenue, by Application (2017-2030)
• 24.4. Market Revenue, by Methodology (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Technique (2017-2030)
• 25.3. Market Revenue, by Application (2017-2030)
• 25.4. Market Revenue, by Methodology (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Technique (2017-2030)
• 26.3. Market Revenue, by Application (2017-2030)
• 26.4. Market Revenue, by Methodology (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Technique (2017-2030)
• 27.3. Market Revenue, by Application (2017-2030)
• 27.4. Market Revenue, by Methodology (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Technique (2017-2030)
• 28.3. Market Revenue, by Application (2017-2030)
• 28.4. Market Revenue, by Methodology (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Merck KGaA
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Agilent Technologies Inc.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Waters Corporation
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. LGC Standards Ltd.
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. PerkinElmer Inc.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. SPEX CertiPrep
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. AccuStandard Inc.
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Thermo Fisher Scientific Inc.
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports